Antibody-Oligonucleotide Conjugates for Multiplex In Situ Protein Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for in situ protein detection face challenges in optimizing molecular techniques for high specificity and sensitivity, particularly in complex cellular environments, requiring improved probe design, target accessibility, and signal amplification strategies, while integrating with microscopy and imaging platforms for accurate visualization and quantification.

Innovation Solution

Development of oligonucleotide conjugates with specific binding agents covalently attached to antibodies, utilizing blocking oligonucleotides and polynucleotide probes for enhanced target detection, including a method for hybridizing and removing blocking oligonucleotides, and employing labeled probes for detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional protein detection methods (immunohistochemistry, fluorescence microscopy) are used, then protein detection can be performed, but sensitivity and specificity are insufficient and multiple proteins cannot be simultaneously detected

Engineering Contradiction:
Improvedetection sensitivity and specificityVSAvoidability to detect multiple proteins
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent combines antibody-based specific binding with oligonucleotide hybridization technology. The antibody-oligonucleotide conjugate integrates two recognition mechanisms: the antibody provides high-specificity protein binding while the oligonucleotide enables sequence-specific hybridization and multiplexing through unique molecular identifiers (UMIs), thereby achieving both high detection precision and multi-protein detection capability

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention creates a composite detection system using antibody-oligonucleotide conjugates where the antibody component provides target specificity and the oligonucleotide component provides signal amplification and multiplexing capability through UMI sequences, combining the advantages of both biological recognition systems to overcome the limitations of traditional single-method approaches

Inventive Principle:
Principle #40Composite materials

2Measurement precision

If molecular techniques are integrated with traditional protein detection, then sensitivity and specificity improve, but the complexity of probe design and target accessibility increases

Engineering Contradiction:
Improvedetection sensitivity and specificityVSAvoidprobe design complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The detection probe is segmented into distinct functional modules: the antibody component for target recognition, the oligonucleotide component for hybridization, and the UMI sequences for identification. This modular segmentation simplifies the overall design process by allowing each component to be optimized independently while maintaining standardized interfaces for assembly

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The oligonucleotide component serves multiple functions simultaneously: it acts as a bridge between the antibody and the detection system, provides a platform for UMI attachment, enables sequence-specific hybridization, and facilitates signal amplification. This multi-functionality reduces the need for separate components, thereby simplifying the overall probe design despite the enhanced capabilities

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If blocking oligonucleotides are used to minimize non-specific binding, then detection specificity improves, but additional steps for hybridizing and removing blocking oligonucleotides are required

Engineering Contradiction:
Improvedetection specificityVSAvoidnumber of detection steps
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Blocking oligonucleotides are applied in advance before the main detection step to pre-occupy non-specific binding sites on the target proteins. This preliminary action prevents non-specific binding of detection probes, ensuring that subsequent signal detection reflects only specific antibody-antigen interactions. The blocking step is performed as a separate preliminary treatment rather than being integrated into the core detection mechanism

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The blocking oligonucleotides are designed to be temporary and removable after serving their protective function. Following the detection step, the blocking oligonucleotides are removed (discarded) since their function is complete, allowing the system to return to its original state for potential reuse or for subsequent detection cycles. This temporary deployment minimizes their impact on the overall process complexity

Inventive Principle:
Principle #34Discarding and recovering

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution enables efficient and specific detection of multiple proteins in situ, minimizing non-specific binding and improving the accuracy of protein detection in cellular and subcellular levels, facilitating advanced biological research and clinical diagnostics.

Implementation Method 1

the oligonucleotide is hybridized to a first blocking oligonucleotide and a second blocking oligonucleotide

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

binding a specific binding agent including an oligonucleotide to the target molecule

Methodology Applied
Scientific EffectSpecific binding:

Data Source

PatentUS20250243532A1Oligonucleotide conjugates useful for in situ target detection
Publication Date: 2025.07.31 SINGULAR GENOMICS SYSTEMS INC
  • US20250243532A1 patent drawing
  • US20250243532A1 patent drawing
  • US20250243532A1 patent drawing

AI summary

Disclosed herein, inter alia, are compositions and methods useful for interrogating a cell and/or tissue.